Blood Market: A $10,253 Million Industry by 2027

𝐈𝐧 2020, 𝐭𝐡𝐞 𝐛𝐥𝐨𝐨𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐢𝐭𝐧𝐞𝐬𝐬𝐞𝐝 𝐚 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐠𝐫𝐨𝐰𝐭𝐡, 𝐰𝐢𝐭𝐡 𝐚 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 $7,201 𝐦𝐢𝐥𝐥𝐢𝐨𝐧. 𝐇𝐨𝐰𝐞𝐯𝐞𝐫, 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲’𝐬 𝐠𝐫𝐨𝐰𝐭𝐡 𝐭𝐫𝐚𝐣𝐞𝐜𝐭𝐨𝐫𝐲 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞 𝐮𝐩𝐰𝐚𝐫𝐝𝐬, 𝐰𝐢𝐭𝐡 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐬 𝐬𝐮𝐠𝐠𝐞𝐬𝐭𝐢𝐧𝐠 𝐭𝐡𝐚𝐭 𝐛𝐲 2027, 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐢𝐥𝐥 𝐞𝐱𝐩𝐚𝐧𝐝 𝐞𝐯𝐞𝐧 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚 𝐬𝐭𝐚𝐠𝐠𝐞𝐫𝐢𝐧𝐠 $10,253 𝐦𝐢𝐥𝐥𝐢𝐨𝐧. 𝐓𝐡𝐢𝐬 𝐫𝐞𝐦𝐚𝐫𝐤𝐚𝐛𝐥𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐬 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 4.5% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝐟𝐫𝐨𝐦 2020 𝐭𝐨 2027.

Blood, a vital bodily fluid, plays a crucial role in maintaining the proper functioning of organs. However, certain chronic medical conditions can lead to a decrease in red blood cells, necessitating blood transfusions. Diseases like leukemia, cancer, and end-stage renal disorders, as well as traumatic injuries resulting in significant blood loss, often require the use of donated whole blood for treatment. Major surgical procedures can also lead to blood loss, making the use of donated blood essential. As a result, there has been a growing demand for whole blood, plasma, and their components in the medical field.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

1. MERCK & CO.
2. HAEMONETICS
3. GRIFOLS INTERNATIONAL SA
4. CSL
5. ABBOTT LABORATORIES
6. F. HOFFMANN-LA ROCHE
7. BIO-RAD LABORATORIES
8. ORTHO CLINICAL DIAGNOSTICS
9. TERUMO CORPORATION (TERUMO BCT
10. NOVO NORDISK A/S

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/request-sample/2297

𝐁𝐥𝐨𝐨𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

Product Categories:
1. Whole Blood Collection and Processing:
• Whole Blood Collection and Processing Systems: This category includes systems used for the collection and processing of whole blood. These systems ensure efficient and safe collection of blood from donors.
• Whole Blood Collection and Processing Consumables: Consumables such as collection bags, anticoagulants, filters, and other necessary components used in the collection and processing of whole blood.

2. Source Plasma Collection:
• Source Plasma Collection Systems: Systems designed for the collection of source plasma, which is plasma collected from donors specifically for manufacturing plasma-derived medicinal products.
• Source Plasma Collection Consumables: Consumables required for the collection of source plasma, including collection sets, needles, and other necessary components.

3. Blood Typing Products:
• Blood Typing Systems: Systems used for determining blood types, including ABO and Rh typing, to ensure compatibility between donors and recipients.
• Blood Typing Reagents: Reagents used in blood typing tests to detect specific antigens and antibodies for accurate blood type determination.

4. Blood Screening Products:
• Blood Screening Systems: Systems used for screening donated blood for infectious diseases and other markers to ensure the safety of the blood supply.
• Blood Screening Reagents: Reagents used in blood screening tests to detect infectious agents, such as viruses or bacteria, and other markers of concern.

End-user Segments:
1. Blood and Blood Component Bank: Facilities that store and distribute blood and its components for various medical needs, including transfusions and other therapies.
2. Diagnostic Laboratories: Laboratories involved in conducting diagnostic tests, including blood typing, blood screening, and other related procedures.
3. Ambulatory Surgical Centers: Outpatient surgical facilities where various surgical procedures are performed, often requiring blood transfusions or related blood products.
4. Hospitals: Healthcare facilities that provide a wide range of medical services, including surgeries, emergency care, and specialized treatments, where blood transfusions and related procedures are common.
5. Others: This category includes additional end users, such as research institutions, academic institutions, and specialty clinics that may require blood products for specific purposes.

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

1. North America:
• United States
• Canada
• Mexico
2. Europe:
• France
• Germany
• Italy
• Spain
• United Kingdom
• Russia
• Rest of Europe
3. Asia-Pacific:
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Malaysia
• Indonesia
• Rest of Asia-Pacific
4. LAMEA (Latin America, Middle East, and Africa):
• Brazil
• South Africa
• Saudi Arabia
• United Arab Emirates
• Argentina
• Rest of LAMEA

𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒?

1. Is there really a black market for blood?
2. How does the blood market operate?
3. What types of blood products are commonly traded on the blood market?
4. Are there legal implications for participating in the blood market?
5. How do people access the blood market?
6. What are the risks involved in buying or selling blood on the black market?
7. Are there any regulations or oversight for the blood market?
8. Can individuals sell their own blood on the blood market?
9. How is the quality and safety of blood products ensured in the blood market?
10. What are the ethical concerns associated with the blood market?

𝐏𝐔𝐑𝐂𝐇𝐀𝐒𝐄 𝐅𝐔𝐋𝐋 𝐑𝐄𝐏𝐎𝐑𝐓: https://www.alliedmarketresearch.com/blood-market/purchase-options